SAN FRANCISCO and SUZHOU, China, Dec. 15, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and...
Read More Details
Finally We wish PressBee provided you with enough information of ( Innovent and Lilly Expand Collaboration Through Agreement on Commercialization Rights for Jaypirca® (pirtobrutinib) in Mainland China )
Also on site :
- Putin says Israel assures safety at Russian-built Iranian nuclear site
- 'The Young and the Restless' Heartthrob, 48, Makes Rare Appearance with Daughter
- '90s Action Legend, 68, Sounds Off on Ditching Acting for Grandma Life